Tag

Tag: Novartis

3tr autoimmune disease eu big pharma

31/10/2019 2 mins

European Project Launches to Tailor Autoimmune Disease Treatments

spinal muscular atrophy zolgensma novartis gene therapy

30/10/2019 2 mins

Trial Testing Spinal Application of Zolgensma Put on Hold by FDA

morphosys galapagos novartis eczema

29/10/2019 1 min

MorphoSys and Galapagos’ Eczema Drug Abandoned at Phase II

CAR-T therapy cancer

10/09/2019 8 mins

A Cure for Cancer? How CAR T-Cell Therapy is Revolutionizing Oncology

cardiology astrazeneca novartis cardiovascular disease

05/09/2019 3 mins

Top Cardiology Biotech News from the ESC Conference 2019

novartis avexis zolgensma fda data manipulation

07/08/2019 2 mins

FDA Considers Imposing Penalties on Novartis over Data Manipulation

novartis spinal muscular atrophy gene therapy

24/05/2019 3 mins

Update: Novartis’ Neurological Gene Therapy Receives FDA Approval

seventure microbiome investment biotech

05/03/2019 2 mins

Seventure Continues Microbiome Investment Success with Second Fund

hookipa cancer vaccine

25/01/2019 2 mins

Swiss-Italian Biotech Bags Antibody Deals with Three Big Pharma

Oculis header - diabetic macular edema

04/01/2019 2 mins

Innovative Eye Disease Therapies Move Closer to the Clinic

gene therapy novartis sma

26/11/2018 1 min

First Gene Therapy for Inherited Blindness Approved in Europe

More News - cover 1

03/09/2018 2 mins

More News! Liquid Biopsy, CAR-T Therapies, and a Failed Lupus Trial…

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.